Statistics in Biopharmaceutical Research

Scope & Guideline

Elevating drug development through innovative statistical solutions.

Introduction

Welcome to the Statistics in Biopharmaceutical Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Statistics in Biopharmaceutical Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1946-6315
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2011 to 2024
AbbreviationSTAT BIOPHARM RES / Stat. Biopharm. Res.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'Statistics in Biopharmaceutical Research' focuses on the application of statistical methodologies to enhance the design, analysis, and interpretation of biopharmaceutical research and clinical trials. It emphasizes innovative statistical techniques that address the complexities of modern biopharmaceutical studies, particularly in the context of regulatory requirements and real-world applications.
  1. Clinical Trial Design and Analysis:
    The journal extensively covers methodologies for designing and analyzing clinical trials, including adaptive designs, Bayesian approaches, and novel statistical frameworks that allow for more flexible and efficient trial processes.
  2. Real-World Evidence and Data Utilization:
    There is a significant emphasis on the integration of real-world data (RWD) and evidence (RWE) into statistical models for clinical trials, highlighting how such data can inform trial design, patient recruitment, and treatment efficacy assessments.
  3. Innovative Statistical Methodologies:
    The journal promotes the development and application of innovative statistical methodologies, including machine learning techniques, advanced modeling approaches, and Bayesian hierarchical models, to address specific challenges in biopharmaceutical research.
  4. Surrogate Endpoints and Biomarker Utilization:
    Research on surrogate endpoints and the use of biomarkers in clinical trials is a core area, focusing on how these tools can be effectively integrated into trial designs and analyses for better decision-making.
  5. Handling Missing Data and Censoring:
    The journal provides insights into modern techniques for handling missing data and censoring in clinical trials, emphasizing the importance of robust methodologies to ensure reliable conclusions.
  6. Multiplicity and Statistical Efficiency:
    A consistent focus is placed on addressing issues of multiplicity in clinical trials, developing strategies that balance statistical efficiency with the rigor required for regulatory compliance.
Recently, 'Statistics in Biopharmaceutical Research' has highlighted several emerging themes that reflect the current trends in the field. These themes showcase the journal's commitment to addressing contemporary challenges in biopharmaceutical statistics and improving clinical trial methodologies.
  1. Adaptive Trial Designs:
    There is a growing trend towards adaptive trial designs, which allow for modifications based on interim data. This reflects the industry's need for more flexible and efficient trial methodologies that can respond to real-time findings.
  2. Integration of Machine Learning Techniques:
    The incorporation of machine learning and artificial intelligence into biostatistics is increasingly prevalent, demonstrating the industry's shift towards leveraging advanced computational techniques for better data analysis and predictive modeling.
  3. Focus on Patient-Centric Approaches:
    Emerging research emphasizes patient-centric trial designs and analyses, considering patient preferences and outcomes, which is becoming crucial in the design of biopharmaceutical studies.
  4. Real-World Evidence and Data Science:
    The utilization of RWE and data science techniques is gaining traction, highlighting the importance of integrating observational data into clinical trial frameworks to enhance the relevance and applicability of research findings.
  5. Statistical Methods for Complex Multi-Arm Trials:
    There is an increasing focus on developing statistical methodologies tailored for complex multi-arm trials, which are common in oncology and other therapeutic areas, aiming to improve the efficiency of these studies.

Declining or Waning

As the field of biopharmaceutical research evolves, certain themes have seen a decline in publication frequency and relevance within the journal. This may reflect shifting priorities in research focus or advancements in statistical methodologies that render previous approaches less critical.
  1. Traditional Hypothesis Testing:
    There appears to be a waning interest in traditional hypothesis testing methods, particularly the use of p-values in favor of more nuanced approaches such as Bayesian methods and targeted learning frameworks.
  2. Fixed-Design Trials:
    The focus on fixed-design trials has diminished as adaptive and flexible trial designs gain prominence. Researchers are increasingly looking for methods that allow for modifications based on interim results.
  3. Single-Endpoint Analyses:
    There is a noticeable decrease in studies focusing solely on single endpoints in clinical trials. Instead, the trend is moving towards composite endpoints and multiple outcomes to capture the complexity of treatment effects.
  4. Conventional Statistical Models:
    The application of conventional statistical models without adaptation to current challenges in biopharmaceutical research is becoming less common, as the field demands more sophisticated and tailored approaches.

Similar Journals

ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS

Elevating Research Standards in Statistical Theory
Publisher: SPRINGER HEIDELBERGISSN: 0020-3157Frequency: 5 issues/year

ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS, published by SPRINGER HEIDELBERG, is a prestigious academic journal that has played a pivotal role in the field of statistical mathematics since its inception in 1949. With a focus on advancing research in statistics and probability, this journal is ranked in the Q2 quartile for 2023, indicating its significance and impact within the academic community. Researchers and professionals engaged in statistical theory and methodology will find the journal's comprehensive coverage of contemporary issues essential for furthering their work and understanding of the discipline. The journal is accessible in print and digital formats, facilitating wide dissemination of knowledge among its readership. With a history of rigorous peer review and a commitment to high-quality research, the ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS continues to be a vital resource for academics and practitioners alike.

JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS

Pioneering advancements in computational and graphical statistics.
Publisher: TAYLOR & FRANCIS INCISSN: 1061-8600Frequency: 4 issues/year

JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS is a premier academic publication dedicated to advancing the fields of computational statistics and graphical data representation. Published by Taylor & Francis Inc, this journal stands out with its impressive Q1 rankings in Discrete Mathematics and Combinatorics, Statistics and Probability, and Statistics, Probability and Uncertainty, reflecting its high impact and relevance in contemporary research. Since its inception in 1992, the journal has been a vital resource for researchers, professionals, and students alike, with its rigorous peer-reviewed articles contributing significantly to the science of data analysis and visualization. With a Scopus ranking placing it within the top tiers of its category, the journal is committed to disseminating high-quality research that promotes innovation and methodological advancement. Note that the journal currently follows a traditional subscription model, ensuring focused and curated content for its readers. As it approaches the horizon of 2024, the JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS continues to foster scholarly discourse and discoveries, making it an essential platform for anyone involved in statistics and data science.

Korean Journal of Applied Statistics

Bridging Theory and Practice in Statistical Research
Publisher: KOREAN STATISTICAL SOCISSN: 1225-066XFrequency: 6 issues/year

Korean Journal of Applied Statistics, published by the Korean Statistical Society, is a prominent journal dedicated to advancing the field of applied statistics. ISSN 1225-066X (Print) and E-ISSN 2383-5818 (Online), this journal serves as a vital platform for disseminating high-quality research that addresses the latest methodologies, applications, and innovations in statistical practices. Though currently not an open-access journal, it aims to foster collaboration among statisticians, researchers, and practitioners by providing rigorous peer-reviewed articles that enhance understanding and application of statistical techniques across various disciplines. With a commitment to integrating theory and practice, the Korean Journal of Applied Statistics stands as a crucial resource for those seeking to influence the evolving landscape of statistical research and its applications in Korea and beyond.

BMC Medical Research Methodology

Exploring New Frontiers in Medical Research Methodology
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Medical Research Methodology is a prestigious open-access journal published by BMC, dedicated to advancing the field of medical research methodologies. Launched in 2001, the journal has established itself as a vital resource for researchers, reflecting its high-quality contributions with a strong Q1 ranking in both Epidemiology and Health Informatics as of 2023. As a scholarly platform, it offers broad access globally, ensuring that the latest developments in research methodology are readily available to professionals, scholars, and students alike. With its commitment to enhancing the rigor and transparency of medical research, BMC Medical Research Methodology plays a critical role in shaping the future of evidence-based practices, making it an essential read for anyone involved in medical research. The journal is based in the United Kingdom at CAMPUS, 4 Crinan St, London N1 9XW, England, and provides comprehensive access options to facilitate the dissemination of knowledge and foster collaboration across the global research community.

JIRSS-Journal of the Iranian Statistical Society

Elevating Research Standards in Statistics and Probability.
Publisher: IRANIAN STATISTICAL SOCISSN: 1726-4057Frequency: 2 issues/year

JIRSS - Journal of the Iranian Statistical Society is a prominent academic journal dedicated to the field of statistics and probability, published by the esteemed Iranian Statistical Society. With its ISSN number 1726-4057 and E-ISSN 2538-189X, this journal serves as a vital platform for disseminating cutting-edge research and advancements in statistical methodology and its applications. Established in 2011, JIRSS has consistently contributed to the academic community, achieving a 2023 Scopus rank of #180 out of 278 in its category, placing it within the 35th percentile in the dynamic domain of Mathematics: Statistics and Probability. As an Open Access publication, it enhances accessibility for researchers, professionals, and students, facilitating a wider engagement with innovative statistical techniques and theories. The journal aims to foster collaboration and knowledge exchange among statisticians, ultimately enriching the field and its impact on various scientific disciplines.

STATISTICAL METHODS IN MEDICAL RESEARCH

Bridging the gap between statistics and healthcare advancements.
Publisher: SAGE PUBLICATIONS LTDISSN: 0962-2802Frequency: 6 issues/year

STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

STATISTICS IN MEDICINE

Pioneering statistical methods for impactful medical insights.
Publisher: WILEYISSN: 0277-6715Frequency: 30 issues/year

Statistics in Medicine, published by Wiley, is a prestigious journal dedicated to the advancement of statistical methods and their application in biomedical research. Established in 1982, this journal has become a cornerstone in the fields of Epidemiology and Statistics and Probability, demonstrating its importance by consistently achieving a Q1 ranking in the 2023 category quartiles. With an impressive ISSN of 0277-6715 and an E-ISSN of 1097-0258, it serves as a vital platform for disseminating high-quality research that enhances evidence-based medicine. Although the journal does not currently offer open access, it remains highly regarded, holding a Scopus rank of #66 in Mathematics and #80 in Medicine, indicating its significant impact on the academic community. By publishing cutting-edge research, Statistics in Medicine aims to bridge the gap between statistical theory and practical application in health domains, fostering a rigorous dialogue among researchers, clinicians, and statisticians alike.

AUSTRALIAN & NEW ZEALAND JOURNAL OF STATISTICS

Unlocking the Potential of Statistics for Tomorrow's Challenges
Publisher: WILEYISSN: 1369-1473Frequency: 4 issues/year

AUSRALIAN & NEW ZEALAND JOURNAL OF STATISTICS, published by Wiley, stands as a significant platform for the dissemination of statistical knowledge and applications, specifically within the realms of statistics and probability. With an impact factor reflective of its quality and standing, the journal operates in a Q3 category for both Statistics and Probability, as well as Statistics, Probability, and Uncertainty, positioning it among the important scholarly resources in its field. As a valuable resource for researchers, professionals, and students, the journal encourages the submission of innovative research articles that push the boundaries of statistical science. Offering both print and open access options, it ensures broad accessibility, promoting a culture of collaboration and knowledge sharing across the global statistical community. Covering research from 1998 to 2024, it remains dedicated to advancing understanding in statistical methodologies and their applications, cementing its role in fostering academic discourse and practical advancements in the field.

JOURNAL OF APPLIED STATISTICS

Empowering researchers with innovative statistical applications.
Publisher: TAYLOR & FRANCIS LTDISSN: 0266-4763Frequency: 12 issues/year

JOURNAL OF APPLIED STATISTICS, published by Taylor & Francis Ltd, is a prestigious scholarly resource that has been at the forefront of advancing the field of statistics since its inception in 1970. With ISSN 0266-4763 and E-ISSN 1360-0532, this esteemed journal focuses on the application of statistical methods across various disciplines, emphasizing practical implementations that provide significant insights into real-world problems. As a Q2 journal in both Statistics and Probability and Statistics, Probability and Uncertainty, it holds remarkable standings in Scopus, with ranks in the 77th and 74th percentiles, respectively. Researchers and professionals will find a wealth of rigorous methodologies and innovative analyses within its pages, aiming to bridge the gap between theory and practice. Although it adopts a traditional subscription model, its extensive archive—from 1970 to the present—offers invaluable resources for statisticians and data analysts. The journal serves as an essential platform for disseminating impactful research, making it a vital tool for students, researchers, and practitioners committed to the advancement of statistical science.

Journal of Biopharmaceutical Statistics

Fostering scientific breakthroughs with precision and rigor.
Publisher: TAYLOR & FRANCIS INCISSN: 1054-3406Frequency: 6 issues/year

Journal of Biopharmaceutical Statistics, published by Taylor & Francis Inc, is a premier scholarly journal that has been contributing to the fields of biostatistics and pharmacology since its inception in 1991. With an impressive track record spanning over three decades, it holds a significant place in the academic landscape, particularly evidenced by its Q2 quartile rankings in Pharmacology, Pharmacology (Medical), and Statistics and Probability as of 2023. The journal serves as a vital platform for researchers, professionals, and students, disseminating critical statistical methodologies and innovative analyses that enhance drug development and biopharmaceutical research. Although not open access, it provides invaluable insights through meticulously peer-reviewed articles that tackle pressing issues in pharmacometric modeling, clinical trial design, and statistical theory. As the biopharmaceutical industry evolves, Journal of Biopharmaceutical Statistics remains pivotal in fostering scientific discovery and excellence.